Ghazaleh Khalili-Tanha Selected Research

Ghazaleh Khalili-Tanha Research Topics

Disease

10	Neoplasms (Cancer) 10/2023 - 01/2021
6	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2023
4	Fibrosis (Cirrhosis) 10/2023 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 07/2022
2	Circulating Neoplastic Cells 01/2023 - 01/2021
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2021 - 01/2021
1	Non-alcoholic Fatty Liver Disease 11/2023
1	Fatty Liver 11/2023
1	Liver Diseases (Liver Disease) 11/2023
1	Atrophy 10/2023
1	Muscular Atrophy (Muscle Atrophy) 10/2023
1	Liver Neoplasms (Liver Cancer) 10/2023
1	Zlotogora-Ogur syndrome 06/2023
1	Cleft palate X-linked 06/2023
1	Pterygium 06/2023
1	Adenocarcinoma 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Tissue Adhesions 01/2022
1	Reinfection 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2021
2	RNA (Ribonucleic Acid)IBA 12/2023 - 10/2023
2	Interleukin-6 (Interleukin 6)IBA 10/2023 - 09/2023
2	MicroRNAs (MicroRNA)IBA 10/2023 - 01/2022
2	Transforming Growth Factor beta (TGF-beta)IBA 09/2023 - 01/2023
2	Fluorouracil (Carac)FDA LinkGeneric 09/2023 - 01/2023
1	WortmanninIBA 04/2024
1	Triglycerides (Triacylglycerol)IBA 11/2023
1	Troponin IIBA 10/2023
1	HydrogenIBA 10/2023
1	Cathepsin WIBA 10/2023
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 09/2023
1	NectinsIBA 06/2023
1	InterferonsIBA 06/2023
1	Gemcitabine FDA Link 01/2023
1	IntegrinsIBA 01/2023
1	EpitopesIBA 01/2023
1	CollagenIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	Cadherins (E-Cadherin)IBA 01/2023
1	pirfenidoneIBA 01/2023
1	Cyclin-Dependent Kinase Inhibitor p15IBA 07/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Telmisartan (Micardis)FDA Link 01/2022
1	Enalapril FDA LinkGeneric 01/2022
1	Renin InhibitorsIBA 01/2022
1	VaccinesIBA 01/2022
1	Valsartan (Vals)FDA Link 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2022
1	AntibodiesIBA 01/2022
1	AngiotensinsIBA 01/2022
1	Long Noncoding RNAIBA 08/2021
1	A-Form DNA (A-DNA)IBA 08/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2021
1	Topoisomerase II InhibitorsIBA 08/2021
1	NivolumabIBA 04/2021
1	Immune Checkpoint InhibitorsIBA 04/2021
1	atezolizumabIBA 04/2021
1	pembrolizumabIBA 04/2021
1	Circulating Tumor DNAIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	InflammasomesIBA 01/2020
1	AntioxidantsIBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2019
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2019

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2021
1	Splints (Splint) 10/2023
1	Immunotherapy 01/2023
1	Precision Medicine 01/2021
1	Drug Therapy (Chemotherapy) 01/2021